What I think Covid-19 variants mean for the Rolls-Royce share price

Jay Yao writes how he thinks Covid-19 variants have affected the Rolls-Royce share price recently and how they might affect the shares in future.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since early December, the Rolls-Royce (LSE:RR) share price is down almost 30%, wiping out some of the gains after the rally that began in October. The fall also means its 12-month decline is 60%+ when factoring in the rights issue’s effects.

Why has this happened just as vaccines seem to offer light at the end of the lockdown tunnel? I see the increasing spread of Covid-19 variants such as the South African and UK strains as a key factor. Some Covid-19 vaccines don’t work as well against the variants. There have been reports that the vaccine made by AstraZeneca isn’t as effective against moderate and mild cases of the South African strain. This has caused some concern among investors over how quick the travel sector’s recovery might be. 

The changing nature of Covid-19 variants could affect the Rolls-Royce share price going forward. After all, RR is very much a share dependent on what’s happening globally, rather than just a successful vaccine rollout in a few countries. But how much could Covid-19 variants affect the Rolls-Royce share price going forward?

Mutating virus

It’s impossible to fully vaccinate everyone against Covid-19 in a very short amount of time. So Covid-19 could always be around and will also very likely continuously mutate. Some mutated strains could spread fast — some commentators have already said the UK strain could become dominant globally.

There’s always the possibility that a mutation gets out of control again before new vaccines arrive. Such mutated strains could severely disrupt air travel’s recovery trajectory.

I think that makes the future of air travel-linked stocks hard to predict. Essentially, the threat of new variants means an airline can’t say that it will make X amount of money next year with as much certainty as before the pandemic. What might his mean for shareholders? I reckon companies might feel the need to have stronger balance sheets than pre-pandemic levels to prepare for any potential declines in travel ahead. That could mean lower capital returns in the near term.

And the Rolls-Royce share price?

Because Rolls-Royce sells jet engines to airlines and maintains them, variants also affect the company. If airlines try to beef up their balance sheets more to protect against potential variant effects, some might delay orders for new jet engines. This could mean a more-drawn-out recovery phase for Rolls-Royce’s civil aviation unit.

How the variants affect the Rolls-Royce share price going forward is unclear given the uncertain nature of mutations. On the upside, if the pandemic can be controlled globally by current vaccines and new vaccines developed quickly to deal with mutations, I see potential for the Rolls-Royce share price to rise.

I think the company’s civil aviation unit will recover, but could take a while to fully do so.

I’d still buy Rolls-Royce shares, however, given the company’s potential in green technologies. Rolls-Royce is a leader in aircraft engines and I think it could be a leader in electric aircraft engines and/or electric aircraft in the future too. This is an area its moving into. With aircraft such as electric air taxis potentially being more convenient than regular land vehicles in many cases, I reckon the market could be huge. If management makes the right decisions, I feel Rolls-Royce has a big growth opportunity ahead that could add a lot of value. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jay Yao has no position in any of the shares mentioned. The Motley Fool UK has recommended The New York Times. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »